Table 2.

Pre–post differences in number of WIE, Wexner score and VAS by gender (ITT)

	Females (N = 34)	Males (N = 5)	All (N = 39)
WIE
V2 – V0	−9.2 (8.20) (− 12.08; – 6.35)*	− 8.5 (7.21) (− 17.45;0.45)	−9.1 (7.99) (− 11.72; – 6.53)*
V3 – V0	− 10.6 (10.50) (− 14.32; – 6.88)*	− 10.5 (10.68) (− 23.71;2.81)	−10.6 (10.37) (− 13.99; – 7.17)*
V4 – V0	−11.0 (10.62) (− 14.66; – 7.25)*	− 10.8 (8.83) (− 21.75;0.18)	−10.9 (10.31) (− 14.27; – 7.59)*
Wexner score
V2 – V0	−14.9 (4.85) (− 16.6; – 13.2)*	− 17.0 (1.00) (− 18.2; – 15.8)*	−15.2 (4.58) (− 16.7; – 13.7)*
V3 – V0	− 15.6 (4.56) (− 17.2; – 14.0)*	−19.0 (1.00) (− 20.2; – 17.8)*	−16.1 (4.41) (− 17.5; – 14.6)*
V4 – V0	− 16.2 (3.66) (− 17.5; – 15.0)*	− 18.8 (1.30) (− 20.4; – 17.2)*	−16.6 (3.55) (− 17.7; – 15.4)*
VAS
V2 – V0	−4.17 (2.27) (− 5.02; – 3.32)*	− 2.59 (1.71) (− 4.71; – 0.47)*	−3.95 (2.25) (− 4.72; – 3.17)*
V3 – V0	−4.01 (2.42) (− 4.92; – 3.11)*	−3.53 (2.11) (− 6.16; – 0.91)*	−3.95 (2.35) (− 4.75; – 3.14)*
V4 – V0	−4.31 (2.65) (− 5.32; – 3.30)*	−4.04 (2.72) (− 7.42; – 0.66)*	−4.27 (2.62) (− 5.19; – 3.36)*

Data presented as mean (standard deviation) (95% confidence interval)

WIE weekly incontinence episodes, VAS visual analogue scale, ITT intention to treat, N number of values, V visit, V0 implantation, V2, V3 and V4 1, 6 and 12 months post implantation

*Significant change from baseline according to 95% confidence interval